jsj schreef op 1 april 2015 20:24:
[...]
DX-2930 is a potent and specific fully
human monoclonal antibody inhibitor
In gewone mensentaal : plasma based, maar dan gekweekt.
We have completed a
Phase 1a clinical study evaluating the safety, tolerability and pharmacokinetics of a single dose of DX-2930 in healthy subjects. For more information on the Phase 1a data click here.
Phase 1, wat kan ik zeggen?
Ga toch met je rare opmerkingen. Draadje mag van mij de prullenbak in